Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: Kill curves versus MICMUELLER, Markus; DE LA PENA, Amparo; DERENDORF, Hartmut et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 369-377, issn 0066-4804, 9 p.Article

Microdialysis in peripheral tissuesDE LA PENA, Amparo; PING LIU; DERENDORF, Hartmut et al.Advanced drug delivery reviews. 2000, Vol 45, Num 2-3, pp 189-216, issn 0169-409XArticle

Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: Distribution in tissueMÜLLER, Markus; DELA PENA, Amparo; DERENDORF, Hartmut et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 5, pp 1441-1453, issn 0066-4804, 13 p.Article

AIR inhaled insulin in subjects with chronic obstructive pulmonary disease : Pharmacokinetics, glucodynamics, safety, and tolerabilityRAVE, Klaus; DE LA PENA, Amparo; TIBALDI, Fabian S et al.Diabetes care. 2007, Vol 30, Num 7, pp 1777-1782, issn 0149-5992, 6 p.Article

Comparative target site pharmacokinetics of immediate- and modified-release formulations of cefaclor in humansDE LA PENA, Amparo; BRUNNER, Martin; EICHLER, Hans-Georg et al.Journal of clinical pharmacology. 2002, Vol 42, Num 4, pp 403-411, issn 0091-2700Article

AIR Inhaled Insulin Versus Subcutaneous Insulin : Pharmacokinetics, glucodynamics, and pulmonary function in asthmaWOLZT, Michael; TIBALDI, Fabian S; DE LA PENA, Amparo et al.Diabetes care. 2008, Vol 31, Num 4, pp 735-740, issn 0149-5992, 6 p.Article

PK-PD modelling of the effect of cefaclor on four different bacterial strainsDE LA PENA, Amparo; GRÄBE, Annemarie; RAND, Kenneth H et al.International journal of antimicrobial agents. 2004, Vol 23, Num 3, pp 218-225, issn 0924-8579, 8 p.Article

Inhaled Growth Hormone (GH) Compared with Subcutaneous GH in Children with GH Deficiency: Pharmacokinetics, Pharmacodynamics, and SafetyWALVOORD, Emily C; DE LA PENA, Amparo; PARK, Soomin et al.The Journal of clinical endocrinology and metabolism. 2009, Vol 94, Num 6, pp 2052-2059, issn 0021-972X, 8 p.Article

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese SubjectsDE LA PENA, Amparo; RIDDLE, Matthew; JACKSON, Jeffrey A et al.Diabetes care. 2011, Vol 34, Num 12, pp 2496-2501, issn 0149-5992, 6 p.Article

Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lisproRAVE, Klaus M; NOSEK, Leszek; DE LA PENA, Amparo et al.Diabetes care. 2005, Vol 28, Num 10, pp 2400-2405, issn 0149-5992, 6 p.Article

Effects of smoking cessation, acute re-exposure and nicotine replacement in smokers on AIR® inhaled insulin pharmacokinetics and glucodynamicsPAN, Alan X; DE LA PENA, Amparo; YEO, Kewee P et al.British journal of clinical pharmacology. 2008, Vol 65, Num 4, pp 480-487, issn 0306-5251, 8 p.Article

Penetration of cefaclor into the interstitial space fluid of skeletal muscle and lung tissue in ratsDE LA PENA, Amparo; DALLA COSTA, Teresa; TALTON, James D et al.Pharmaceutical research. 2001, Vol 18, Num 9, pp 1310-1314, issn 0724-8741Article